NCT00385437View on ClinicalTrials.gov

Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

June 30, 2004

Conditions
DepressionExcessive Daytime Sleepiness
Interventions
BEHAVIORAL

Driving Simulator Testing

DRUG

Mirtazapine Treatment

Trial Locations (1)

M5T 2S8

University Health Network, Toronto

Sponsors

Collaborators (1)

Organon
All Listed Sponsors
collaborator

Organon

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT00385437 - Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter